Evidence map›Paper›PMID 35782013›Full record

ArticleEvolutionary applications2022

Host mixtures for plant disease control: Benefits from pathogen selection and immune priming.

Pauline Clin, Frédéric Grognard, Didier Andrivon, Ludovic Mailleret, Frédéric M Hamelin

Abstract read
In one paragraph

Article in Evolutionary applications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Fungal Disease Tolerance with a Focus on Wheat: A Review.Journal of fungi (Basel, Switzerland) · 2024
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pauline ClinInstitut Agro, INRAE, IGEPP Univ Rennes Rennes France.
Frédéric GrognardInria, INRAE, CNRS, Sorbonne Université, Biocore Université Côte d'Azur Nice France.
Didier AndrivonInstitut Agro, INRAE, IGEPP Univ Rennes Rennes France.
Ludovic MailleretINRAE, CNRS, ISA Université Côte d'Azur Nice France.
Frédéric M HamelinInstitut Agro, INRAE, IGEPP Univ Rennes Rennes France.ORCID https://orcid.org/0000-0003-2653-699X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiline and cultivar mixtures are highly effective methods for agroecological plant disease control. Priming-induced cross protection, occurring when plants are challenged by avirulent pathogen genotypes and resulting in increased resistance to subsequent infection by virulent ones, is one critical key to their lasting performance against polymorphic pathogen populations. Strikingly, this mechanism was until recently absent from mathematical models aiming at designing optimal host mixtures. We developed an epidemiological model to explore the effect of host mixtures composed of variable numbers of single-resistance cultivars on the equilibrium prevalence of the disease caused by pathogen populations polymorphic for virulence complexity. This model shows that a relatively large amount of resistance genes must be deployed to achieve low disease prevalence, as pathogen competition in mixtures tends to select for intermediate virulence complexity. By contrast, priming significantly reduces the number of plant genotypes needed to drop disease prevalence below an acceptable threshold. Given the limited availability of resistance genes in cultivars, this mechanism of plant immunity should be assessed when designing host mixtures.

Indexed as

durable management of resistancegene‐for‐gene interactioninduced resistancesustainable agriculturesystemic acquired resistancevirulence

Identifiers

PMID35782013
PMCPMC9234633

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.